Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 2007/DELNP/2007
Who filed: Cancer Patient Aid Association (CPAA)
Country: India
Opposition type: Pre-Grant
Opposition status: Granted
Date: 30-06-2017
Patent type: Molecules

Click within the document, or manually enter the page number below

Tapan Shah opposition, Rucaparib, (6460/CHENP/2012)

Countries: India Date: 2017
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)

Countries: Argentina Date: 2017
Cancer Patient Aid Association (CPAA) opposition, imatinib (ITB) , (1602/MAS/98 )

Countries: India Date: 2005
Cipla Ltd. opposition, sunitinib (su) , (IN/PCT/2002/00785/DEL )

Countries: India Date: 2012
Natco Pharma Ltd. opposition, Paclitaxel, (2899/DELNP/2005)

Countries: India Date: 2014
CILFA opposition, CERITINIB, (AR100625A1)

Countries: Argentina Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005))

Countries: India Date: 2017
Vector Biosciences Pvt Ltd opposition, Sofosbuvir, (IN273003 (6087/DELNP/2005) )

Countries: India Date: 2017
Vector Biosciences Pvt Ltd opposition, Sofosbuvir, (3658/KOLNP/2009)

Countries: India Date: 2017
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Sofosbuvir, (9149/CHENP/2012)

Countries: India Date: 2017

Cancer Patient Aid Association (Cpaa) Opposition, Vismodegib, (2007/Delnp/2007)